
Captor Therapeutics ®
News

October 13, 2023
Captor Therapeutics has selected ICON as the CRO company to conduct the first phase of clinical trials under the CT-01 project

September 23, 2023
Captor Therapeutics will raise PLN 40 million from share issue for implementation of strategic goals

September 11, 2023
Captor Therapeutics appoints Wedbush as its exclusive strategic financial advisor and establishes relationship with MSQ Ventures in China

September 08, 2023
Captor Therapeutics publishes financial report for the first half of 2023

July 18, 2023
Captor Therapeutics with PLN 52.2 million co-funding from The Medical Research Agency of Poland

May 29, 2023
Captor Therapeutics publishes Q1 2023 financial results

April 07, 2023
Captor Therapeutics has published its 2022 report. The past year was a period of dynamic growth for the Company in both science and business.

March 27, 2023
Captor Therapeutics Discloses Molecular Targets of Pipeline’s Lead Assets and Invites Stakeholders to Webcast